Uncategorized

EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study

EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating the potential of EyeGate’s Ocular Bandage Gel (OBG) to help clinicians better manage patients with punctate epitheliopathies (PE) due to pathologies such as dry eye.

Click here to read the whole article